2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow Chemoradiation: new trials by email Literature Review of Chemoradiation trials Research Report on Chemoradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC Tislelizumab, Paclitaxel, Carboplatin - Esophageal Squamous Cell Carcinoma, Tislelizumab | Phase 1 / Phase 2 | Unknown | Jiangsu Cancer Institute & Hospital | 30 | 2022-05-01 | 2022-05-27 |
| Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer Hypo-fractionated radiotherapy, S1 - Gastric Cancer, Chemoradiation | Phase 1 / Phase 2 | Unknown | Chinese Academy of Medical Sciences | 18 | 2016-05-01 | 2018-02-09 |
Esophageal Squamous Cell Carcinoma (1) · Stomach Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Esophageal Diseases (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Squamous Cell (1) · Stomach Diseases (1)
Carboplatin (1) · Paclitaxel (1) · Radiotherapy (1) · S 1 (combination) (1) · tislelizumab (1)
Chinese Academy of Medical Sciences (1) · Jiangsu Cancer Institute & Hospital (1)
China (2)